CITIDARON Tablet Ref.[116734] Active ingredients: Cytisine

Source: Health Products Regulatory Authority (IE)  Revision Year: 2025  Publisher: Aflofarm Farmacja Polska Sp. z o.o., Partyzancka 133/151, Pabianice 95-200, Poland

Product name and form

Citidaron 1.5 mg tablets.

Pharmaceutical Form

Tablet.

Round, biconvex, white tablet with diameter 6 mm.

Qualitative and quantitative composition

Each tablet contains 1.5 mg of cytisinicline (previously used name: cytisine).

For the full list of excipients, see section 6.1.

Active Ingredient

Cytisine is a plant alkaloid with a chemical structure similar to nicotine. The use of cytisine allows for a gradual reduction of nicotine dependence by relieving withdrawal symptoms. The action of cytisine is similar to that of nicotine, but in general weaker. Cytisine competes with nicotine for the same receptors and gradually displaces nicotine due to its stronger binding.
List of Excipients

Mannitol
Cellulose, microcrystalline
Magnesium stearate
Glycerol dibehenate
Hypromellose

Pack sizes and marketing

PVC/PCTFE/Aluminium or PVC/PE/PVDC/Aluminium blisters placed into cardboard box containing 100 tablets.

Marketing authorization holder

Aflofarm Farmacja Polska Sp. z o.o., Partyzancka 133/151, Pabianice 95-200, Poland

Marketing authorization dates and numbers

PA22714/001/001

Date of first authorisation: 5th March 2018
Date of last renewal: 9th of August 2022

Drugs

Drug Countries
CITIDARON Ireland
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈